Literature DB >> 20833343

The dimensions of the CRC problem.

L V Karsa1, T A Lignini, J Patnick, R Lambert, C Sauvaget.   

Abstract

Colorectal cancer is a significant health problem, the importance of which will increase substantially in the coming years, both in more, as well as in less developed regions of the world. The present paper describes the dimensions of the problem from an epidemiologic viewpoint as well as from the perspective of policy makers and professionals seeking to control the disease. Currently, colorectal cancer is the third most common cancer and the fourth most common cause of cancer deaths worldwide, with 1.2 million estimated cases and 609,000 estimated deaths in 2008. Based on demographic trends, the annual incidence is expected to increase by nearly 80% to 2.2 million cases over the next two decades and most of this increase will occur in the less developed regions of the world (62%). These regions are ill equipped to deal with the rapidly increasing demand for cancer treatment resulting from population growth and higher life expectancy. Concerted efforts to control colorectal cancer are therefore of great importance worldwide. They will require allocation of additional resources and should be based on an appropriate balance between prevention, diagnosis and treatment.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20833343     DOI: 10.1016/j.bpg.2010.06.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  61 in total

1.  Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins.

Authors:  Federico Tomassini; Italo Bonadio; Peter Smeets; Karen De Paepe; Giammauro Berardi; Liesbeth Ferdinande; Stéphanie Laurent; Louis J Libbrecht; Karen Geboes; Roberto I Troisi
Journal:  Langenbecks Arch Surg       Date:  2015-08-12       Impact factor: 3.445

2.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

3.  LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells.

Authors:  Yu-Hao Zhang; Jun Fu; Zhi-Jin Zhang; Cui-Cui Ge; Yi Yi
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway.

Authors:  Yuqi Luo; Jun Ouyang; Donggen Zhou; Shizhen Zhong; Minjie Wen; Wentao Ou; Haitao Yu; Lin Jia; Yaoxin Huang
Journal:  Dig Dis Sci       Date:  2018-02-09       Impact factor: 3.199

5.  Expression of fibulin-1 predicted good prognosis in patients with colorectal cancer.

Authors:  Jing Zhu; Rui Chen; Lijuan Mo; Haimei Tang; Yeye Kuang; Weiqiang Fei; Chao He; Xiaotong Hu
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

6.  An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Authors:  Gregory C Knapp; Avinash Sharma; Bolatito Olopade; Olusegun I Alatise; Olalekan Olasehinde; Olujide O Arije; Philip E Castle; T Peter Kingham
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

7.  High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

8.  The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer.

Authors:  M Cavia-Saiz; P Muñiz Rodríguez; B Llorente Ayala; M García-González; M J Coma-Del Corral; C García Girón
Journal:  Mol Biol Rep       Date:  2014-01-17       Impact factor: 2.316

9.  TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.

Authors:  Jing Zhu; Xijun Chen; Zhongcai Liao; Chao He; Xiaotong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

10.  Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.

Authors:  Encheng Zhou; Qing Huang; Ji Wang; Chengfeng Fang; Leilei Yang; Min Zhu; Jianhui Chen; Lihua Chen; Milian Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.